Published: Jan. 15, 2026 at 11:51 a.m. ET Millions of Americans have tried GLP-1s, but some people…
Novo Nordisk A/S ADR
Rising prices and weight-loss drugs are changing the way we eat — and food companies are racing to keep up
A shaky economy, wider adoption of weight-loss drugs, and changing tastes seem to conspire against some…
Wegovy’s prices are going down, but they are ‘wildly different’ — and confusing
How much Novo Nordisk’s weight-loss drug Wegovy costs can depend on a lot of things, which…
Novo Nordisk’s oral GLP-1 drug didn’t work on Alzheimer’s as hoped, and the stock tumbles
Novo Nordisk’s stock tumbles after its oral GLP-1 drug failed to show much benefit over a…
Why biotech and drug stocks are on the mend even though the rest of the market is hurting
Published: Nov. 18, 2025 at 4:21 p.m. ET Biopharma is back, and it’s smarter, slimmer and more…
This biotech is halting its work with Novo Nordisk and laying off more people
Korro is the latest to rethink its ties with the Danish pharma company.
Why Trump’s ‘Great Healthcare Plan’ strikes Wall Street as so underwhelming
The Trump administration on Thursday rolled out what it’s calling the “Great Healthcare Plan,” with elements…